Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pitchai Balakumar

Showing results (61-70 of 93) with videos related to

Pageof 10
Sort By:
European Journal of Pharmacology|March 10, 2015
A step ahead of PPARγ full agonists to PPARγ partial agonists: therapeutic perspectives in the management of diabetic insulin resistanceSridevi Chigurupati, Sokkalingam A Dhanaraj, Pitchai Balakumar
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|May 8, 2009
Possible role of JAK-2 in attenuated cardioprotective effect of ischemic preconditioning in hyperhomocysteinemic rat heartsGurfateh Singh, Ankur Rohilla, Manjeet Singh, et al.
Pharmacological Research|July 17, 2017
Renin-angiotensin-aldosterone: An inclusive, an invigorative, an interactive and an interminable systemPitchai Balakumar, Madhu B Anand-Srivastava, Gowraganahalli Jagadeesh
Clinical and Experimental Nephrology|May 15, 2014
Nephroprotective effect of catechin on gentamicin-induced experimental nephrotoxicityAnkush Sardana, Sanjeev Kalra, Deepa Khanna, et al.
Fundamental & Clinical Pharmacology|May 6, 2016
Chronic oral administration of low-dose combination of fenofibrate and rosuvastatin protects the rat heart against experimentally induced acute myocardial infarctionMonika Garg, Deepa Khanna, Sanjeev Kalra, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 1, 2008
Vascular endothelial dysfunction: a tug of war in diabetic nephropathy?Pitchai Balakumar, Vishal Arvind Chakkarwar, Pawan Krishan, et al.
Pharmacology & Therapeutics|November 4, 2025
A map of molecular drug targets and therapeutics for the US FDA-approved drugs: The impact of expedited regulatory pathways and first-in-class drug approvals on drug innovationPitchai Balakumar, N V L Sirisha Mulukuri, Gowraganahalli Jagadeesh
Methods and Findings in Experimental and Clinical Pharmacology|May 21, 2009
Modulation of cardioprotective effect of ischemic pre- and postconditioning in the hyperhomocysteinemic rat heartPitchai Balakumar, Ankur Rohilla, Gurfateh Singh, et al.
Journal of Molecular and Cellular Cardiology|October 5, 2011
Is targeting eNOS a key mechanistic insight of cardiovascular defensive potentials of statins?Pitchai Balakumar, Sonam Kathuria, Gaurav Taneja, et al.
Pharmacological Research|May 12, 2009
The impairment of preconditioning-mediated cardioprotection in pathological conditionsPitchai Balakumar, Harsimran Singh, Manjeet Singh, et al.
Pageof 10

Showing results (61-70 of 93) with videos related to

Sort By:
Pageof 10
European Journal of Pharmacology|March 10, 2015
A step ahead of PPARγ full agonists to PPARγ partial agonists: therapeutic perspectives in the management of diabetic insulin resistanceSridevi Chigurupati, Sokkalingam A Dhanaraj, Pitchai Balakumar
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|May 8, 2009
Possible role of JAK-2 in attenuated cardioprotective effect of ischemic preconditioning in hyperhomocysteinemic rat heartsGurfateh Singh, Ankur Rohilla, Manjeet Singh, et al.
Pharmacological Research|July 17, 2017
Renin-angiotensin-aldosterone: An inclusive, an invigorative, an interactive and an interminable systemPitchai Balakumar, Madhu B Anand-Srivastava, Gowraganahalli Jagadeesh
Clinical and Experimental Nephrology|May 15, 2014
Nephroprotective effect of catechin on gentamicin-induced experimental nephrotoxicityAnkush Sardana, Sanjeev Kalra, Deepa Khanna, et al.
Fundamental & Clinical Pharmacology|May 6, 2016
Chronic oral administration of low-dose combination of fenofibrate and rosuvastatin protects the rat heart against experimentally induced acute myocardial infarctionMonika Garg, Deepa Khanna, Sanjeev Kalra, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 1, 2008
Vascular endothelial dysfunction: a tug of war in diabetic nephropathy?Pitchai Balakumar, Vishal Arvind Chakkarwar, Pawan Krishan, et al.
Pharmacology & Therapeutics|November 4, 2025
A map of molecular drug targets and therapeutics for the US FDA-approved drugs: The impact of expedited regulatory pathways and first-in-class drug approvals on drug innovationPitchai Balakumar, N V L Sirisha Mulukuri, Gowraganahalli Jagadeesh
Methods and Findings in Experimental and Clinical Pharmacology|May 21, 2009
Modulation of cardioprotective effect of ischemic pre- and postconditioning in the hyperhomocysteinemic rat heartPitchai Balakumar, Ankur Rohilla, Gurfateh Singh, et al.
Journal of Molecular and Cellular Cardiology|October 5, 2011
Is targeting eNOS a key mechanistic insight of cardiovascular defensive potentials of statins?Pitchai Balakumar, Sonam Kathuria, Gaurav Taneja, et al.
Pharmacological Research|May 12, 2009
The impairment of preconditioning-mediated cardioprotection in pathological conditionsPitchai Balakumar, Harsimran Singh, Manjeet Singh, et al.
Pageof 10